BY MARIA OUTZE NIELSEN
-
New Valve data highlights Steam Deck games that dominated playtime in 2025
Valve has put up a comprehensive list that puts the top games users have played or bought throughout the year 2025. Called the “Best of 2025,” this chart also has a ded…
-
COMAU MỞ RỘNG DANH MỤC ROBOT CỘNG TÁC VỚI DÒNG ROBOT CỘNG TÁC MYCO
THƯỢNG HẢI, ngày 19 tháng 12 năm 2025 /PRNewswire/ — Comau tiếp tục mở rộng danh mục robot cộng tác của mình với MyCo, một dòng sản phẩm mới gồm sáu robot cộng tác được thiết kế nhằm hỗ trợ sự hợp tác an toàn, linh hoạt và hiệu quả giữa con người và robot trong nhiều
-
United States Capacity Utilization below expectations (77.7%) in May: Actual (77.4%)
United States Capability Utilization beneath expectations (77.7%) in Might: Precise (77.4%…Read More
-
AbbVie cancer drug fails in phase 3 combination trial
AbbVie’s hit medicine Venclexta has actually been examined in mix with common medicine Azacitidine.
-
Pfizer boss after meeting with Trump team: “I don’t know what we will hear in 30 days”
Pfizer chief executive officer Albert Bourla really hopes that medicine rates in Europe will certainly climb following stress in the United States.
-
Novo Nordisk’s lack of CEO replacement reveals “dramatic nature of the process”
It is essential that Novo Nordisk did not have a substitute for the leading placement all set prior to shooting Lars Fruergaard Jørgensen, onlookers inform media.
-
Novo Nordisk culture put to the test after pivotal year
The substantial success of Wegovy and Ozempic might test Novo Nordisk’s self-image, teacher states.
-
Leo Pharma presents new HR director
Helle Hedegaard Juhl is currently component of a brand-new monitoring group at Leo Pharma.
-
Zealand Pharma seeks EMA approval of short bowel syndrome drug
The medication prospect glepaglutide is a long-acting GLP-2 analog for the therapy of brief digestive tract disorder.
-
Gilead cancer drug achieves target in breast cancer trial
Gilead’s cancer cells medicine Trodelvy has actually additionally been examined in mix with MSD’s multiblockbuster Keytruda.
